Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Shoshana Gordon/Axios

The Mu variant of the coronavirus is something to monitor — as it appears to partially evade immunity from authorized COVID-19 vaccines — but Delta's continued dominance means "Mu is not any immediate threat," NIAID director Anthony Fauci tells Axios.

Why it matters: Sounding the alarm, Fauci says widespread vaccination is a priority to fight the coronavirus and cut down on the rate of new infections — which is currently 10 times higher than where it needs to be.

What's happening: The WHO recently labeled Mu (B.1.621 and first discovered in Colombia) a variant of interest as preliminary data indicated it may better elude immunity from prior infection or vaccination.

  • Mu may "indicate potential properties of immune escape, as it has some of these hallmarks of being able to get around that existing vaccine protection, but it doesn't mean that's what we're seeing play out in real life," says Anne Rimoin, an epidemiologist and director of the UCLA Center for Global and Immigrant Health.
  • Fauci says when comparing how specific variants may escape antibody protection, Beta appears more evasive than Mu, and Mu more than Delta.
  • Only about 0.5% of new cases are showing as Mu, Fauci says, with 99.3% testing as Delta, which has such an "extraordinary ability" to transmit that it won't likely lose its global dominance in the immediate future.

Between the lines: While some have raised concerns it may be time to look at updating the vaccines to better match these variants, Fauci says that's not needed as the current vaccines "do very well against the Delta variant."

  • "Even though the vaccine wasn't specifically [designed] against Delta, there's enough cross-protection against the different variants once you get the antibody level high enough," he says.
  • But a third dose may be needed to "extend that immunity," Rimoin says.

Yes, but: If a new variant came along that evaded antibodies and was transmissible enough to dominate Delta, scientists would take quick action, Fauci says.

  • The mRNA vaccine platform enables the development of a new version of the vaccine within roughly three months, and the FDA is expected to treat these similarly to the flu shot, as a "strain change" that can be approved relatively quickly, he adds.
  • Gigi Gronvall, an immunologist and senior scholar at the Johns Hopkins Center for Health Security, says the FDA is close to deciding what the correlates of immunity should be for COVID. These would give an indication of the minimum amount of antibodies, T-cells and other immune responders that a vaccine should generate.

"The biggest problem — the 10 elephants in the room — is the fact that we need to get people vaccinated, so we don't have people dying as much every day," Gronvall says.

  • "The biggest push has to be to get transmission down," she says, "because the unvaccinated are creating problems for the vaccinated, and they're dying, basically, of a vaccine-preventable disease."
  • Fauci says the U.S. remains in a pandemic because it doesn't have "even modestly good control," with 160,000 new cases a day when it needs to be below 10,000 a day.

The big picture: Global vaccination is key to halting this pandemic — to protect every individual from severe disease or death, to lessen the probability of long COVID, and to prevent a monster variant from developing.

  • After all, Rimoin says, globalization has ensured that "an infection anywhere is potentially an infection everywhere."

Read more from the interview with Fauci here.

Go deeper

Updated 9 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Pfizer coronavirus vaccine safe, effective in children, company says — The COVID booster vaccine discussion is far from over — Cuba becomes first country to begin mass vaccination of children.
  2. Health: Chicago has highest COVID-19 case rates in city worker neighborhoods — International Mission Board to require COVID vaccine for missionaries.
  3. Politics: Biden administration to lift travel ban for fully vaccinated international travelers — Footage shows new details after NYC restaurant incident over proof of vaccination.
  4. Education: More schools using "test-to-stay" strategy to minimize quarantines — Most Kentucky school boards vote in favor of mask mandates —Denver looks to students to close Latino vaccination gap.
  5. Variant tracker: Where different strains are spreading.
15 hours ago - Health

Pfizer coronavirus vaccine safe, effective in children, company says

Photo by Mario Tama/Getty Images

Pfizer and BioNTech's coronavirus vaccine is safe and effective in children ages 5 to 11, albeit at a lower dose than adults receive, the companies said in a press release announcing results from a pediatric trial.

Why it matters: The trial results are a much-needed source of hope for families with elementary school-aged children, who currently aren't eligible for a vaccine.

14 hours ago - Health

Chicago has highest COVID-19 case rates in city worker neighborhoods

Maps show COVID-19 positivity rates (left) are highest in two ZIP codes where the highest concentrations of Chicago municipal workers happen to live (right). Illustration: Brendan Lynch/Axios

COVID hot spots have moved all over Chicago in the past 18 months, but in recent weeks, the highest rates have emerged in two ZIP codes on the far Southwest and Northwest Sides, according to city data.

  • 60655 covers parts of Beverly, Morgan Park and Mount Greenwood.
  • 60656 covers parts of Jefferson Park and Norwood Park.